OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ulcerative colitis: understanding its cellular pathology could provide insights into novel therapies
Amandip Kaur, Paraskevi Goggolidou
Journal of Inflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

Pathophysiology of Inflammatory Bowel Disease: Innate Immune System
Ángela Saéz, Beatriz Herrero‐Fernández, Raquel Gómez-Bris, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1526-1526
Open Access | Times Cited: 259

Luteolin alleviates inflammation and modulates gut microbiota in ulcerative colitis rats
Bolin Li, Pengli Du, Yao Du, et al.
Life Sciences (2021) Vol. 269, pp. 119008-119008
Open Access | Times Cited: 167

Hypoxia: A key feature of COVID-19 launching activation of HIF-1 and cytokine storm
Mozhgan Jahani, Sadat Dokaneheifard, Kamran Mansouri
Journal of Inflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 142

Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression?
Eduardo J. Villablanca, Katja Selin, Charlotte Hedin
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 8, pp. 493-507
Closed Access | Times Cited: 127

The Role of Innate and Adaptive Immune Cells in the Pathogenesis and Development of the Inflammatory Response in Ulcerative Colitis
Aleksandra Kałużna, Paweł Olczyk, Katarzyna Komosińska‐Vassev
Journal of Clinical Medicine (2022) Vol. 11, Iss. 2, pp. 400-400
Open Access | Times Cited: 118

Microencapsulation and Probiotic Characterization of Lactiplantibacillus plantarum LM-20: Therapeutic Application in a Murine Model of Ulcerative Colitis
Cynthia Garfias Noguez, Morayma Ramírez Damián, A. Moreno, et al.
Nutrients (2025) Vol. 17, Iss. 5, pp. 749-749
Open Access | Times Cited: 2

Non-classical monocyte homing to the gut via α4β7 integrin mediates macrophage-dependent intestinal wound healing
Lena Schleier, Maximilian Wiendl, Karin Heidbreder, et al.
Gut (2019) Vol. 69, Iss. 2, pp. 252-263
Closed Access | Times Cited: 97

Astragaloside Ⅳ alleviates ulcerative colitis by regulating the balance of Th17/Treg cells
Youbao Zhong, Wenjun Liu, Yanxia Xiong, et al.
Phytomedicine (2022) Vol. 104, pp. 154287-154287
Closed Access | Times Cited: 45

Mechanistic insights into the role of probiotics in modulating immune cells in ulcerative colitis
Ni Guo, Lu‐lu Lv
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 10
Open Access | Times Cited: 31

Chronic Gastrointestinal Disorders and miRNA-Associated Disease: An Up-to-Date
Alessandro Giammona, Bruno G. Galuzzi, Elena Imperia, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 413-413
Open Access | Times Cited: 1

Subsets of mononuclear phagocytes are enriched in the inflamed colons of patients with IBD
Hong Liu, Suryasarathi Dasgupta, Yu Fu, et al.
BMC Immunology (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 56

Role of inner mitochondrial protein OPA1 in mitochondrial dysfunction by tobacco smoking and in the pathogenesis of COPD
Krishna P. Maremanda, Isaac K. Sundar, Irfan Rahman
Redox Biology (2021) Vol. 45, pp. 102055-102055
Open Access | Times Cited: 55

Berberine promotes M2 macrophage polarisation through the IL-4-STAT6 signalling pathway in ulcerative colitis treatment
Kai Xiong, Jia Deng, Tinghui Yue, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e14176-e14176
Open Access | Times Cited: 20

Natural approaches for the management of ulcerative colitis: evidence of preclinical and clinical investigations
Rudra Narayan Subudhi, Neelam Poonia, Dilpreet Singh, et al.
Natural Products and Bioprospecting (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7

Immunological mechanisms underpinning faecal microbiota transplantation for the treatment of inflammatory bowel disease
Mohammed Nabil Quraishi, Walaa Shaheen, Ye Htun Oo, et al.
Clinical & Experimental Immunology (2019) Vol. 199, Iss. 1, pp. 24-38
Open Access | Times Cited: 52

Gut Microbiota and Related Metabolites Were Disturbed in Ulcerative Colitis and Partly Restored After Mesalamine Treatment
Liang Dai, Yingjue Tang, Wenjun Zhou, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 38

A review of the biological and pharmacological activities of mesalazine or 5-aminosalicylic acid (5-ASA): an anti-ulcer and anti-oxidant drug
Mohammad Beiranvand
Inflammopharmacology (2021) Vol. 29, Iss. 5, pp. 1279-1290
Closed Access | Times Cited: 35

Prebiotics for induction and maintenance of remission in ulcerative colitis
Vassiliki Sinopoulou, Morris Gordon, Vicki L. Gregory, et al.
Cochrane library (2024) Vol. 2024, Iss. 3
Closed Access | Times Cited: 6

Nuciferine alleviates intestinal inflammation by inhibiting MAPK/NF-κB and NLRP3/Caspase 1 pathways in vivo and in vitro
Uttam Kulhari, Sourav Kundu, Madhav Nilakanth Mugale, et al.
International Immunopharmacology (2022) Vol. 115, pp. 109613-109613
Closed Access | Times Cited: 19

Page 1 - Next Page

Scroll to top